Physician profile
Eugene C Hsiao
NPI 1144359647
$7,411.65
in general payments reported to CMS, 2019-2025
15 companies · $1,449 in 2025
The $1,449 reported for 2025 was more than what 80% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,358 · 2020: $491 · 2021: $717 · 2022: $1,395 · 2023: $932 · 2024: $1,069 · 2025: $1,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,449.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $2,088.89 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $1,380.91 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $1,147.96 | 2023-2025 | |
| Allergan, INC. | $1,014.11 | 2019-2022 | |
| Sientra, INC. | $967.46 | 2019-2022 | |
| Motiva USA, LLC | $194.76 | 2025 | |
| Axogen | $186.72 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $120.25 | 2022-2023 | |
| Depuy Synthes Sales INC. | $84.12 | 2020 | |
| Acera Surgical, INC. | $65.32 | 2025 | Restrata Wound Matrix |
| Davol INC. | $64.68 | 2019-2025 | Surgiphor, Arista Ah Flexitip |
| Medtronic, INC. | $33.79 | 2022 | |
| Innovation Technologies INC | $22.76 | 2024 | Irrisept |
| Ethicon US, LLC | $21.97 | 2019 | |
| Avita Medical Americas, LLC | $17.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Hsiao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.